Carl Dambkowski, M.D., is a distinguished medical professional currently serving as the Chief Medical Officer at Apogee Therapeutics Inc. With an extensive background in clinical development and medical affairs, Dr. Dambkowski brings a wealth of experience to his role at Apogee. He earned his medical degree from a prestigious institution and has since dedicated his career to advancing healthcare through innovative therapeutic solutions. Prior to joining Apogee, Dr. Dambkowski held significant positions at several leading biopharmaceutical companies, where he played a pivotal role in the development and commercialization of groundbreaking treatments. At Apogee Therapeutics Inc., Dr. Dambkowski is responsible for overseeing the company's clinical development strategy and medical affairs. His leadership is instrumental in guiding the company's mission to develop transformative therapies for patients with serious diseases. Under his guidance, Apogee has made significant strides in advancing its pipeline of novel therapeutics, with a focus on unmet medical needs. Dr. Dambkowski's expertise in clinical trial design and execution has been crucial in driving the company's research and development efforts forward. Throughout his career, Dr. Dambkowski has been recognized for his contributions to the field of medicine. He has authored numerous publications in peer-reviewed journals and is a frequent speaker at industry conferences. His commitment to improving patient outcomes and advancing medical science continues to be a driving force behind his work at Apogee Therapeutics Inc. Dr. Dambkowski's strategic vision and dedication to excellence make him an invaluable asset to the company as it works to bring life-changing therapies to patients around the world.